NAUT · 10-Q · 2026Q1 · Full report

Investing Activities and Securities

Nautilus Biotechnology, Inc. · 2026-04-28 · Importance 53 · Surprise 48

Net cash provided by investing activities was $14.2 million in Q1 2026, driven by $25.8 million of proceeds from maturities of securities partially offset by $11.1 million of purchases of securities and $0.5 million of property and equipment purchases. For the three months ended March 31, 2025, investing activities provided $19.5 million, driven by $26.6 million in proceeds from maturities and offset by $6.9 million in purchases of securities and $0.2 million of property and equipment. The company’s investing activity reflects active management of short‑term securities maturities and reinvestments which materially affected cash balances during the quarter. Net investing inflows helped offset operating cash outflows in Q1 2026.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
cashpositiverealized+13.5%During the three months ended March 31, 2026, net cash provided by investing activities resulted from $25.8 million in proceeds from…
cashnegativerealized-5.8%During the three months ended March 31, 2026, net cash provided by investing activities resulted from $25.8 million in proceeds from…
cashnegativerealized-0.3%During the three months ended March 31, 2026, net cash provided by investing activities resulted from $25.8 million in proceeds from…
assetspositiverealized+0.3%During the three months ended March 31, 2026, net cash provided by investing activities resulted from $25.8 million in proceeds from…